BioSpace News Archive

Press Releases

Mesoblast Draws US$50 Million from Five-Year Non-Dilutive Facility

June 25, 2026
·
6 min read
Press Releases

Innovent’s Partner Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of IBI324 (OLN324) in DME and Wet AMD; Studies Commencing in Second Half of 2026

June 25, 2026
·
7 min read
Press Releases

Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

June 25, 2026
·
5 min read
Press Releases

C-Ray Therapeutics Receives Radiopharmaceutical Manufacturing Authorization under China’s MAH Framework

June 25, 2026
·
2 min read
Press Releases

Addex Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

June 25, 2026
·
5 min read
Press Releases

IBA to install the first proton therapy center in Brazil in Rio de Janeiro

June 25, 2026
·
3 min read
Press Releases

AnaCardio´s Phase 1b/2a GOAL-HF1 study in patients with Heart Failure and Reduced Ejection Fraction (HFrEF) published in The Lancet

June 25, 2026
·
5 min read
Press Releases

Herantis appoints experienced drug development expert Dr Juha Savola as Chief Medical Officer

June 25, 2026
·
6 min read
Press Releases

Innovative Molecules Announces First Patient Dosed in Phase 2a Trial of Adibelivir (IM-250), Advancing Company into Late-Stage Clinical Development

June 25, 2026
·
2 min read
Press Releases

Ionis announces license agreement with Recordati for zilganersen in Alexander disease (AxD) in all countries outside the U.S.

June 25, 2026
·
7 min read